HB-EGF Sustained Release for Tympanic Membrane Healing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for chronic tympanic membrane perforations are often invasive, require microsurgical skills, and are costly, limiting their accessibility and effectiveness in achieving complete healing.
Innovation Solution
Topical application of heparin-binding epidermal growth factor (HB-EGF) in a sustained release formulation, either biodegradable or through a delivery device, to promote healing of the tympanic membrane perforation, potentially combined with inhibitors to create or manage perforations as needed.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional therapy including tissue grafts and microsurgical procedures is used to treat chronic TM perforation, then healing success rate is improved, but procedure complexity and cost increase
Solution Approach 1:
The invention extracts and isolates the critical healing factor (HB-EGF) from the complex surgical procedure. By identifying and delivering only the essential growth factor needed for epithelial migration and perforation closure, the treatment removes unnecessary surgical complexity while maintaining healing efficacy.
Solution Approach 2:
The invention uses an intermediary delivery system (sustained-release formulation or device) to transport HB-EGF to the perforation site. This intermediary mechanism replaces the need for direct surgical intervention, providing controlled delivery of the active ingredient while simplifying the overall treatment protocol.
2Reliability
If tissue grafts and microsurgical procedures are used for TM repair, then complete healing is achieved, but treatment cost and accessibility are worsened
Solution Approach 1:
The invention employs a disposable sustained-release formulation or device that delivers HB-EGF and then degrades or is discarded after use. This approach eliminates the need for expensive, reusable surgical equipment and facilities, making treatment more accessible while maintaining complete healing outcomes.
Solution Approach 2:
The sustained-release formulation serves itself by automatically delivering HB-EGF over time without requiring continuous medical intervention. The formulation or device handles the entire treatment course independently, reducing the need for specialized surgical services and improving accessibility.
3Duration of action of moving object
If sustained release formulation is used to deliver HB-EGF, then healing effectiveness is improved, but formulation complexity increases
Solution Approach 1:
The invention changes the release parameter of HB-EGF from immediate to sustained delivery. By modifying the formulation's release kinetics rather than its fundamental composition, the treatment achieves prolonged healing effectiveness while keeping the formulation relatively simple and based on conventional materials.
Data Source
AI summary
Compositions and methods are provided for the generation or treatment of chronic tympanic membrane perforation by modulation of HB-EGF activity.